Paul Anthony Williams - Jul 8, 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
SVP, Products Business
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Jul 8, 2023
Transactions value $
$0
Form type
4
Date filed
7/24/2023, 08:29 AM
Previous filing
Jun 13, 2023
Next filing
Nov 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $0 -85 -0.32% $0.00 26.1K Jul 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.

Remarks:

This Form 4 was filed late due to an inadvertent administrative error. The Company will report all late Form 4s in it's next proxy statement.